Synapse - Works

Results (115370)

Evaluating inpatient care team models in hematology and oncology fellowship programs in the United States

Meeting Abstract

Stempel, J. M.; Li, A. J.; Pine, A. B.; Restrepo, V.; Bewersdorf, J. P.; Stahl, M.; Podoltsev, N. A.; Mendez, L.; Shallis, R. M.; Rangachari, D.; more...
Blood (2023)

Fulltext@MSK | Save

Trial in progress: An open-label expansion trial evaluating the safety, PK/PD, and clinical activity of emavusertib (CA-4948) + ibrutinib in R/R primary CNS lymphoma

Meeting Abstract

Grommes, C.; Nowakowski, G. S.; Rosenthal, A. C.; Lunning, M. A.; Ramchandren, R.; Regales, L.; Fowle, M.; Lane, M.; Wang, C.; Omuro, A.; more...
Blood (2023)

Fulltext@MSK | Save

High-dose targeted radiation with (131)I-apamistamab prior to HCT demonstrated a dose-response for durable complete remission in patients with R/R AML

Meeting Abstract

Litzow, M. R.; Chen, G.; Gyurkocza, B.; Nath, R.; Seropian, S.; Choe, H.; Abboud, C. N.; Koshy, N.; Tomlinson, B. K.; Abhyankar, S.; more...
Blood (2023)

Fulltext@MSK | Save

Trial in progress: Venetoclax in combination with ASTX727, an all-oral therapy for chronic myelomonocytic leukemia and other MDS/MPN with excess blasts (VICTORY MDS/MPN): A randomized, phase 2 trial

Meeting Abstract

Shallis, R. M.; Blaha, O.; Halene, S.; Mendez, L.; Podoltsev, N. A.; Caldwell, A.; Bewersdorf, J. P.; Little, R. F.; Piekarz, R.; Patnaik, M. M.; more...
Blood (2023)

Fulltext@MSK | Save

A phase 1 study of avapritinib in combination with decitabine in patients with systemic mastocytosis with an associated hematologic neoplasm

Meeting Abstract

Kuykendall, A. T.; Ball, S.; Gotlib, J.; Yi, C. Y. A.; Tashi, T.; Rampal, R. K.; DeAngelo, D. J.; Volpe, V. O.; Pettit, K. M.; Komrokji, R. S.; more...
Blood (2023)

Fulltext@MSK | Save

Ibrutinib in combination with revlimid/dexamethasone (RD) in relapsed/refractory multiple myeloma (AFT-15)

Meeting Abstract

Efebera, Y.; Suman, V. J.; Dinner, S. N.; Rosko, A. E.; McKay, J. T.; Barth, P.; Hagen, P.; Usmani, S. Z.; Richardson, P. G.; Laubach, J. P.
Blood (2023)

Fulltext@MSK | Save

High response rates following point-of-care anti-CD19 CAR T-cell therapy in adults with relapsed/refractory acute B lymphoblastic leukemia

Meeting Abstract

Fried, S.; Danylesko, I.; Marcus, R.; Itzhaki, O.; Yerushalmi, R.; Shem-Tov, N.; Sdayoor, I.; Shouval, R.; Jacoby, E.; Kedmi, M.; more...
Blood (2023)

Fulltext@MSK | Save

Longitudinal assessment of minimal residual disease (MRD) in the ATLAS randomized phase 3 trial of post-transplant treatment with carfilzomib, lenalidomide, and dexamethasone (KRd) versus lenalidomide (R) alone in patients with newly diagnosed multiple myeloma (NDMM)

Meeting Abstract

Kubicki, T.; Dytfeld, D.; Wrobel, T.; Jamroziak, K.; Robak, P.; Czyz, J.; Tyczynska, A.; Druzd-Sitek, A.; Giannopoulos, K.; Nowicki, A.; more...
Blood (2023)

Fulltext@MSK | Save

Bendamustine bridging versus standard of care chemotherapy on toxicity profile for multiple myeloma patients undergoing CAR T cell therapy

Meeting Abstract

Leyfman, Y.; Rajeeve, S.; Sheng, T.; Diniz, M.; Richard, S.; Jagannath, S.; Rossi, A. C.
Blood (2023)

Fulltext@MSK | Save

Updated results on a multicenter phase II study of a dose intensified pediatric regimen in adults with acute lymphoblastic leukemia: The 06-254 DFCI ALL consortium trial

Meeting Abstract

Valtis, Y. K.; Flamand, Y.; Shimony, S.; Place, A. E.; Silverman, L. B.; Vrooman, L. M.; Brunner, A. M.; Sallan, S. E.; Wadleigh, M.; Garcia, J. S.; more...
Blood (2023)

Fulltext@MSK | Save